The FTSE 100’s Hottest Growth Stocks: British American Tobacco plc

Royston Wild explains why British American Tobacco plc (LON: BATS) is an exceptional earnings selection.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Today I am outlining why British American Tobacco (LSE: BATS) (NYSE: BTI.US) could be considered a terrific stock for growth hunters.

Earnings expansion grinding to a halt

The addictive nature of tobacco smoking means that British American Tobacco and its peers have long been favourites for those seeking reliable earnings and dividend expansion. Indeed, the London-based firm’s earnings’ record over the past five years alone pays testament to this, with earnings rising at a compound annual growth rate of 9% since 2009.

But more recesmokingntly the impact of macroeconomic turmoil on customers’ wallets, growing concerns over the health implications of tobacco smoking, a rising black market, and the introduction of a raft of anti-smoking legislation in key markets has caused earnings increases to slow markedly.

These issues are expected to result in British American Tobacco’s first earnings dip for many moons, and a 3% decline, to 211.8p per share, has been pencilled in for this year by City analysts.

… but e-cigs should blast growth higher

Still, I believe that the cigarette giant is in terrific shape to punch robust earnings growth over the longer-term. Indeed, forecasters currently expect British American Tobacco’s resurgence to kick off from next year, when a 9% advance is anticipated, taking earnings to 230.1p per share.

The business has several levers that it can pull to help drive group sales higher in coming years, the most exciting of which is its position at the coalface of e-cigarette technology. British American Tobacco launched its Vype product last July, after it acquired vapouriser developers CN Creative in late 2012, and has aggressively ramped up marketing spend and retail distribution in recent months to boost the new technology’s profile.

With a host of product innovations and roll-outs also apparently scheduled from next year, British American Tobacco is firmly nailing its colours to the e-cigarette mast, as smokers seek an alternative to traditional products. The debate rages on over how much safer the new products are than conventional cigarettes, but booming demand — worldwide sales clocked in at $3bn in 2013 — suggests that users are certainly convinced by the benefits of the revolutionary technology.

On top of this, I reckon that the firm’s stable of traditional tobacco products — including the likes of prestigious labels Lucky Strike and Dunhill — should enjoy splendid revenues growth once pressure on consumers’ wallets in crucial emerging markets eases. The regions of Latin America and Asia are home to the lion’s share of the world’s smokers, and I believe that rising population levels and increased spending power here should underpin long-term sales expansion.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »